on SARTORIUS STED BIO (EPA:DIM)
Sartorius Stedim Biotech Updates Share and Voting Rights Information
Sartorius Stedim Biotech S.A., based in Aubagne, France, has released information regarding its share capital and voting rights as of June 30, 2026. The announcement states that the company currently has an issued capital comprising 97,330,405 shares. The total number of theoretical voting rights, including treasury shares, stands at 164,770,927. Excluding the treasury shares, the net voting rights total 164,731,078.
This declaration adheres to Article L 233-8-II of the French Code of Commerce and Article 223-6 of the general regulations of the AMF. The information is disseminated by EQS Group, as part of the regulatory requirements.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news